Ondansetron
Product Images NDC 67296-1321

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67296-1321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg (30)

This text is a prescription label for Ondansetron Orally Disintegrating Tablets, USP manufactured by AUROBINDO. It includes information on the dosage, storage conditions, and distribution details, as well as a cautionary note about not removing the tablet from the blister pack until immediately before use. The tablets meet the USP Disintegration Test 2 and should be dispensed in a tightly closed, light-resistant container as per USP guidelines.*

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

FDA Label Image

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))

This is a description for Ondansetron Orally Disintegrating Tablets, USP by AUROBINDO. Each orally disintegrating tablet contains Ondansetron USP 8 mg. The tablets are recommended for the treatment of nausea and vomiting. It is essential to follow the recommended dosage and administration instructions provided in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F). They should be dispensed in a tight, light-resistant container. This medication meets USP Disintegration Test 2 standards. Distributed by Aurobindo Pharma USA, it is made in India.*

FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

This text is a description of Ondansetron Orally Disintegrating Tablets, USP manufactured by AUROBINDO. The tablets contain USP and are intended for oral consumption. Each package consists of 30 tablets divided into 3 blister cards with 10 tablets each. It provides dosage and administration instructions and warns against removing the tablets from the blister pack until immediately before use. The product should be stored between 20°C to 25°C. The text also includes distribution information for Aurobindo Pharma USA, based in East Windsor, NJ.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.